IL4R and breast neoplasm: Guruprasath developed a SPION-based system for dual gene therapy-chemotherapy that carried an IL-4R binding peptide for active targeting and Bcl-xL-targeting siRNA, which sensitized IL-4R-expressing MDA-MB231 breast tumor cells to chemotherapy and enhanced the cytotoxicity of DOX 178.